Maria Edebrink
Consigliere Generale presso XBRANE BIOPHARMA AB
Patrimonio netto: 4 641 $ in data 30/04/2024
Profilo
Maria Edebrink currently works at Xbrane Biopharma AB, as Head-Regulatory Affairs & Quality Assurance from 2021.
Ms. Edebrink also formerly worked at Medivir AB, as Head-Regulatory Affairs and AstraZeneca AB, as Head-Regulatory Affairs.
Ms. Edebrink received her graduate degree from the University of Stockholm.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
XBRANE BIOPHARMA AB
0.02% | 05/09/2023 | 235 210 ( 0.02% ) | 4 641 $ | 30/04/2024 |
Posizioni attive di Maria Edebrink
| Società | Posizione | Inizio |
|---|---|---|
| XBRANE BIOPHARMA AB | Consigliere Generale | 01/01/2019 |
Precedenti posizioni note di Maria Edebrink
| Società | Posizione | Fine |
|---|---|---|
| MEDIVIR AB | Consigliere Generale | - |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Consigliere Generale | - |
Formazione di Maria Edebrink
| University of Stockholm | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| XBRANE BIOPHARMA AB | Health Technology |
| MEDIVIR AB | Health Technology |
| Aziende private | 1 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
- Borsa valori
- Insiders
- Maria Edebrink
